Consolidated balance sheet
Assets
in CHF 1,000 | Note | 31.12.2021 | 31.12.2020 | Variance | Variance |
---|---|---|---|---|---|
Cash and cash equivalents | 2,384,137 | 2,592,706 | –208,569 | –8.0 | |
Receivables arising from money market papers | 129,401 | 116,166 | 13,235 | 11.4 | |
Due from banks | 1,688,870 | 1,784,320 | –95,450 | –5.3 | |
Due from customers | 6,237,258 | 6,281,529 | –44,271 | –0.7 | |
Trading portfolios | 10,483 | 290 | 10,193 | n.a. | |
Derivative financial instruments | 46,875 | 79,491 | –32,616 | –41.0 | |
Financial instruments at fair value | 195,927 | 182,936 | 12,991 | 7.1 | |
Financial instruments measured at amortised cost | 2,263,236 | 2,201,303 | 61,933 | 2.8 | |
Joint venture companies | 24 | 25 | –1 | –4.0 | |
Property and equipment | 95,192 | 108,156 | –12,964 | –12.0 | |
Goodwill and other intangible assets | 84,108 | 66,679 | 17,429 | 26.1 | |
Tax receivables | 297 | 159 | 138 | 86.8 | |
Deferred tax assets | 7,592 | 10,173 | –2,581 | –25.4 | |
Accrued receivables and prepaid expenses |
| 34,779 | 32,429 | 2,350 | 7.2 |
Other assets | 18,251 | 66,989 | –48,738 | –72.8 | |
Total assets |
| 13,196,430 | 13,523,351 | –326,921 | –2.4 |
Liabilities and shareholders’ equity
in CHF 1,000 | Note | 31.12.2021 | 31.12.2020 | Variance | Variance |
---|---|---|---|---|---|
Due to banks |
| 70,886 | 250,426 | –179,540 | –71.7 |
Due to customers – savings and deposits |
| 575,204 | 589,784 | –14,580 | –2.5 |
Due to customers – other liabilities |
| 10,883,533 | 10,921,871 | –38,338 | –0.4 |
Derivative financial instruments | 82,309 | 104,371 | –22,062 | –21.1 | |
Medium-term notes | 53,997 | 76,148 | –22,151 | –29.1 | |
Debentures issued | 255,134 | 355,205 | –100,071 | –28.2 | |
Tax liabilities | 10,970 | 12,208 | –1,238 | –10.1 | |
Deferred tax liabilities | 859 | 141 | 718 | n.a. | |
Accrued liabilities and deferred items |
| 37,065 | 36,085 | 980 | 2.7 |
Other liabilities | 139,781 | 151,243 | –11,462 | –7.6 | |
Provisions | 1,125 | 812 | 313 | 38.5 | |
Total liabilities |
| 12,110,863 | 12,498,294 | –387,431 | –3.1 |
Share capital | 66,154 | 66,154 | 0 | 0.0 | |
Less: treasury shares | –56,790 | –61,071 | 4,281 | 7.0 | |
Capital reserves |
| 22,959 | 23,377 | –418 | –1.8 |
Retained earnings |
| 1,134,088 | 1,107,739 | 26,349 | 2.4 |
Actuarial gains/losses from defined-benefit |
| –34,105 | –57,859 | 23,754 | 41.1 |
Unrealised gains/losses on FVTOCI financial instruments |
| –18,587 | –23,332 | 4,745 | 20.3 |
Foreign-currency translation differences |
| –28,152 | –29,951 | 1,799 | 6.0 |
Total shareholders’ equity |
| 1,085,567 | 1,025,057 | 60,510 | 5.9 |
Total liabilities and shareholders’ equity |
| 13,196,430 | 13,523,351 | –326,921 | –2.4 |